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ABSTRACT 
Objective: This study was designed to analyze the prescription pattern of prophylactic antimicrobial agents used in preoperative patients.  
Methods: A descriptive observational study was done at a tertiary care teaching hospital in Potheri from July to December 2013 after obtaining of 
Institutional Ethics Committee clearance.  
Results: Total 284 patients were included in this study, out of which 141(49.6%) were females and 143(50%) were males. In the department of 
general surgery, the very commonly used antimicrobial agents were cefotaxime (81%) followed by cefoperazone sodium (42%). In the orthopaedics 
department, the frequently used antimicrobial agents were cefoperazone and sulbactam (39%) followed by cefazolin (29%). Most commonly used 
antimicrobial agent was cefotaxime (100%) in gynaecology department.  
Conclusion: Antimicrobial prophylaxis is helpful in declining the frequency of post-operative infections. This study explained about the various 
antimicrobial agents used prior to surgeries. Practitioners must prescribe an antibiotic based on their hospital antibiotic policy. 
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Prophylactic Antibiotic refers to “prevention of infection and its 
complication by using antimicrobial agents prior to any surgical 
procedures”. In spite of numerous available aseptic precautions, 
antimicrobial agents, advanced sterilization procedures and 
operative techniques, the Surgical Site Infection (SSI) is one of the 
most important crises in the field of surgery [1]. The definition of 
surgical site infection is that, the occurrence of infection at or near 
the surgical site within 30 d or a year followed by any surgical 
procedure [2]. Around two million cases had developed a surgical 
site infection worldwide [3]. SSI is the second most common 
nosocomial infection and cause of many post-operative 
complications [4]. The rate of morbidity and mortality are more in 
SSI and it increases the expense and duration of hospital stay for the 
surgical patients [5, 6]. SSI also produces delayed wound healing, 
augmented use of antibiotics and multidrug antibiotic resistance [7]. 
The causes for the SSI could be due to poor hygiene, existing 
infection, anaemia, diabetes, obesity and improper techniques which 
can be overcome by proper prophylactic antibiotic usage [8]. 
Surgeries like coronary bypass, hip and knee prosthesis and 
exploratory abdominal surgeries showed higher rates of SSI [9]. The 
commonest pathogens isolated were Staphylococcus aureus, 
Escherichia coli, Klebsiella sp. Coagulase-negative Staphylococci, 
Pseudomonas aeruginosa, Proteus mirabilis [8]. Prophylaxis could be 
defined based on timing of administration of antimicrobial agents 
and categorized as early operative where it was scheduled before 
one hour of incision, pre-operative prophylaxis when it was given 
less than two hours prior to incision and peri-operative 
prophylaxis,if it was planned at the time of surgery and 
postoperative prophylaxis given after the completion of surgery 
[10]. Prophylactic antibiotics should be stopped within 24 h of 
surgery and within 48 h in cardiothoracic surgeries [5]. The 
commonest prophylactic antimicrobial agents used are, first and 
second-generation cephalosporins and vancomycin in patients who 
are hypersensitive to β-lactam antibiotics [11, 12]. The criteria for a 
prophylactic antibiotic are, good efficacy against infective 
microorganisms, achievement of sufficient local tissue levels, 
minimal side effects and relatively at a lower cost (13). The aim of 
the present is to identify the common antimicrobial agents used 
prophylactically in various surgeries.  
MATERIALS AND METHODS 
The present study was a descriptive observational study done at 
SRM Medical College Hospital and Research Centre which was 
carried out from July to December 2013 after obtaining the 
Institutional Ethics Committee clearance (415/IEC/2013). Patients, 
undergoing surgery in the department of general surgery, 
orthopaedics and gynaecology were included in this study based on 
inclusion and exclusion criteria’s. After getting the oral informed 
consent from the patient, the data like age, gender, date of 
admission, diagnosis, co-morbid conditions, date and type of 
surgery, name and details of prophylactic antimicrobial agents given 
were analyzed and entered in individual proforma. Follow-up was 
done for any evidence of postoperative infections. Data were 
analyzed using SPSS version 17.0 and results were expressed as a 
percentage. 
RESULTS 
A total of 284 patients were included in the study, out of which 
141(49.6%) were females and 143(50.4%) were males. In the 
department of general surgery, the surgeries performed frequently were 
appendicectomy (21%) followed by hernioplasty (17%), abdominal 
meshplasty (15%), haemorrhoidectomy (13%), cholecystectomy (9%), 
lipoma and granuloma excision (7%). In the above conditions, the 
commonest antimicrobial agents used were cefotaxime (81%) followed 
by cefoperazone sodium (42%), ceftriaxone (25%), amoxicillin with 
clavulanate (20%) and metronidazole (14%) (table 1, fig. 1). 
In the orthopaedics department, surgeries done very often were 
Open Reduction and Internal Fixation-ORIF (43%), plate and screw 
fixation (21%), laminectomy and discectomy (10%). In these, the 
commonest antimicrobial agents used were cefoperazone with 
sulbactam (39%), cefazolin (29%), cefoperazone sodium (28%), 
gentamicin (25%) and cefuroxime (20%) (table 2, fig. 2). 
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Table 1: Types of surgeries and antimicrobial agents used in the department of general surgery 
Name of surgery No. of cases N=148 Name of Antimicrobial agent 
Hernioplasty 29(17%) Cefotaxime(75%) 
Cefoperazonesodium(10%) 
Ceftriaxone and Tazobactam(06%) 
Ceftriaxone and Sulbactam(06%) 
Haemorrhoidectomy 21(13%) Cefotaxime(71%) 
Ceftriaxone and Tazobactam(19%) 
Abdominal meshplasty 24(15%) Cefotaxime(62%) 
Ceftriaxone and Sulbactam(16%) 
Ceftriaxone and Tazobactam(08%) 
Appendicectomy 34(21%) Cefotaxime(55%) 
Metronidazole(14%) 
Ceftriaxone and Sulbactam(08%) 
Ciprofloxacin(06%) 
Cholecystectomy 09(6%) Cefotaxime(66%) 
Cefoperazonesodium(33%) 
Lipoma and Granuloma excision 07(4.7%) Cefotaxime(100%) 
Skin graft 06(4%) Cefotaxime(66%) 
Cefoperazonesodium(16%) 
Amoxicillin and Clavulanate(16%) 
Fibroadenoma excision 06(4%) Cefotaxime(100%) 
Secondary suture 03(2%) Cefotaxime(100%) 
Wound debridement 04(2.7%) Ceftriaxone(25%) 
Cefotaxime(25%) 
Cefoperazonesodium(25%) 
Amoxicillin and Clavulanate(25%) 
Radical Mastectomy 03(2%) Cefotaxime(100%) 
Thyroidectomy 01(1%) Cefoperazonesodium(100%) 
Colectomy 01(1%) Cefotaxime(100%) 
 
 
Fig. 1: Pattern of antimicrobial agents used in general surgery 
 
Table 2: Types of surgeries and antimicrobial agents used in the department of orthopaedics 
Name of surgery Number of cases N=67 Name of Antimicrobial agent 
Open Reduction and Internal Fixation(ORIF) 29(43%) Cefoperazonesodium (31%) 
Cefoperazone and Sulbactam (27%) 
Cefazolin (17%) 
Plate and screw fixation  14(21%) Cefoperazonesodium (42%) 
Cefoperazone and Sulbactam (42%) 
Cefazolin (21%) 
Laminectomy and Dissectomy 07(10%) Cefoperazone and Sulbactam (85%) 
Arthrodesis 05(7%) Cefoperazonesodium (20%) 
Cefoperazone and Sulbactam (20%) 
Cefuroxime (20%) 
Implant removal 05(7%) Cefoperazonesodium (20%) 
Cefoperazone and Sulbactam (40%) 
Cefuroxime (20%) 
Wound debridement  04(4%) Cefazolin (50%) 
Cefoperazone and Sulbactam (25%) 
Gentamicin (25%) 




Fig. 2: Pattern of antimicrobial agents used in orthopaedics 
 
In the gynaecology department, the common surgeries done were 
Total Abdominal Hysterectomy with Bilateral Salphingo 
Oophrectomy-TAHBSO (43%), vaginal hysterectomy (12%), 
laparotomy hysterectomy (5%) and myomectomy (4%), where the 
antimicrobial agent prescribed was, only cefotaxime (100%) 
(table 3). 
 
Table 3: Types of surgeries and antimicrobial agents used in the department of gynaecology 
Name of surgery No. of cases N=70 Name of antimicrobial agent 
TAHBSO 43(61%) Cefotaxime(100%) 
Vaginal hysterectomy 12(17%) Cefotaxime(100%) 
Laparotomy hysterectomy 05(7%) Cefotaxime(100%) 
Myomectomy 04(5.7%) Cefotaxime(100%) 
 
DISCUSSION 
The usage of prophylactic antimicrobial agents has significantly 
reduced the mortality and morbidity in the postoperative patients. 
Standard antibiotic prophylactic guidelines recommended the use of 
these agents prior to surgery. Nowadays, it has been made 
mandatory to use these drugs to minimize the surgical risk due to 
infection. The present study was done, to find out the pattern of 
prophylactic antimicrobial agents that were used in the departments 
of general surgery, orthopaedics and gynaecology. A total of 284 
patients were included in the study. All antimicrobial agents were 
given one hour prior to surgery. The dose was based on the 
particular antimicrobial agent. In the department of general surgery, 
the common surgeries performed were appendicectomy (21%) 
followed by hernioplasty (17%), abdominal meshplasty (15%) and 
haemorrhoidectomy (13%). In these surgeries, the common 
antimicrobial agents used were cefotaxime (81%) followed by 
cefoperazone sodium (42%), ceftriaxone (25%) and amoxicillin with 
clavulanate (20%). The first three drugs belong to the third 
generation cephalosporin. Since the third generation cephalosprin is 
having a wide spectrum activity, it has become a preferred drug to 
be used as a prophylactic agent. According to Garcia-Rodriguez JA et 
al.,the frequency of wound infections in the cefotaxime group was 
less (3.3%) when compared to cefoxitin group(7.6 %) which is a 
second-generation cephalosporin [14]. Another study by Woodfield 
stated that, both ceftriaxone and cefotaxime along with 
metronidazole were highly effective and well comparable in their 
efficacy [15]. Amoxicillin and clavulanate were mainly used in skin 
graft and wound debridement in the present study. A study, 
published in vascular journal explained that, 95% of the organisms 
cultured from the skin preoperatively were sensitive to 
amoxicillin/clavulanic acid which has a suitable spectrum and tissue 
penetration [16]. Ciprofloxacin, ceftriaxone with sulbactam and 
ceftriaxone with tazobactam were used in appendicectomy, 
haemorrhoidectomy and hernioplasty surgeries in the present 
study. The common orthopedic surgeries done were ORIF (43%), 
plate and screw fixation (21%), laminectomy and dissectomy (10%). 
In these surgeries the preferred antimicrobial agents used were 
cefoperazone with sulbactam (39%), cefazolin (29%) and 
cefoperazone sodium (28%). Since the staphylococcus aureus 
infection is most common in orthopaedic surgeries, above said 
antimicrobials were commonly used which was confirmed by the 
protocol,“Antibiotic Prophylaxis to Prevent Surgical Site Infections” 
by Alan et al.,. In the present study, cefuroxime was mainly used in 
implant removal and arthrodesis cases which were also mentioned 
in the protocol [5]. Injection gentamicin was used in cases like 
wound debridement against gram negative infection in the present 
study which was supported by a study done by Adrienne J et al., [17]. 
The frequent gynaecology surgeries were TAHBSO (43%), vaginal 
hysterectomy (12%), laproscopic hysterectomy (5%) and 
myomectomy (4%). In these surgeries, an antimicrobial agent used 
was cefotaxime (100%). Cefotaxime was the common antimicrobial 
agent used as a monotherapy and also combined with the other 
group of antibiotics in most of the surgeries, specified in a study 
done by peter et al.,[18]. A similar study done by Brethiset al., stated 
that the use of cefotaxime was 20.7% followed by metronidazole 
19.1% [19]. A study by Amol M et al., compared cefotaxime with 
various groups and defined that, the short course and long course of 
various antimicrobial therapy did not differ considerably [20]. After 
the follow-up, none of the patients showed any postoperative 
infections. The present study emphasized, that the chosen 
antimicrobials proved to be an effective prophylactic agent.  
CONCLUSION 
Reduction of surgical site infections decreases the postoperative 
morbidity, mortality and wastage of healthcare resources. Prolonged 
operative time, wound class, and wound contamination influence the 
wound infections. Antimicrobial prophylaxis is helpful in declining the 
frequency of post-operative infections. This study explains about the 
various antimicrobial agents used in surgeries. Practitioners must 
implement antibiotic prophylaxis based on the antibiotic policy. 
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